3rd Quarter - Report

NATIONAL ASSOCIATION OF CHAIN DRUG STORES for NATIONAL ASSOCIATION OF CHAIN DRUG STORES

Firm
Client
Income
—
Expenses
$720,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

H.R.2647/S.1390/S.1391, National Defense Authorization Act for Fiscal Year 2010, as related to pharmacy participation in the TRICARE program.

LobbyistCovered position, as disclosed
STEVEN C ANDERSON —
YONG CHOE —
HEIDI ANN ECKER —
KATHERINE FRY —
CAROL KELLY —
PAUL T KELLY —
JULIE A KHANI —
MARC SCHLOSS —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Consumer Product Safety Commission (CPSC); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); White House Office; Drug Enforcement Administration (DEA); Office of Natl Drug Control Policy (NDCP); Health & Human Services, Dept of (HHS)

Bills named: S. 1391 (111th), S. 1390 (111th), H.R. 2647 (111th)

Labor Issues/Antitrust/Workplace LBR

H.R.1409/S.560, the Employee Free Choice Act of 2009, as related to labor practices in the workplace.

LobbyistCovered position, as disclosed
STEVEN C ANDERSON —
YONG CHOE —
HEIDI ANN ECKER —
KATHERINE FRY —
CAROL KELLY —
PAUL T KELLY —
JULIE A KHANI —
MARC SCHLOSS —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Consumer Product Safety Commission (CPSC); Office of Natl Drug Control Policy (NDCP); Environmental Protection Agency (EPA); White House Office; Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: S. 560 (111th), H.R. 1409 (111th)

Pharmacy PHA

H.R.1, the American Recovery and Reinvestment Act, as related to health information technology and state Medicaid programs. H.R. 1259, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. S. 726, Promoting Innovation and Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements. H.R.759, Food and Drug Administration Globalization Act of 2009, as related to the safety of prescription drugs. H.R. 1191/S.1336, Safe Drug Disposal Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 1256, the Family Smoking Prevention and Tobacco Control Act, as related to the importation of prescription drugs. H.R. 1298/S.525,S.1232, Pharmaceutical Market Access and Drug Safety Act, as related to the importation of prescription drugs. H.R. 1359, Secure and Responsible Drug Disposal Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 1450, Counterfeit Drug Prevention Act of 2009, as related to the prosecution of prohibited acts related to prescription drugs. H.R. 1548, Pathway for Biosimilars Act, as related to the approval of generic biopharmaceuticals by the FDA. H.R. 1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exemption from the Medicare Bart B surety bond requirement. H.R. 2552, Medical Waste Management Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 2923/S.256, Combat Methamphetamine Enhancement Act, as related to the abuse of methamphetamine. H.R. 2997/S.1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010, as related to the importation of prescription drugs. H.R. 3108, the Medication Therapy Management Benefits Act, as related to an expanded MTM program in the Medicare Part D program. H.R. 3200, America's Affordable Health Choices Act of 2009, related to changes in pharmacy Medicaid reimbursement and the role of pharmacy and pharmacists in healthcare reform. H.R. 3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME Program. S.1383, Dextromethorphan Abuse Reduction Act, as related to the abuse of dextromethorphan. S.___, Americas Healthy Future Act of 2009, related to changes in pharmacy Medicaid reimbursement and the role of pharmacy and pharmacists in healthcare reform. Various issues related to the role of pharmacy and pharmacists in healthcare reform, including pharmacy services in the Medicare program.

LobbyistCovered position, as disclosed
STEVEN C ANDERSON —
YONG CHOE —
DIANE L DARVEY —
HEIDI ANN ECKER —
KATHERINE FRY —
CAROL KELLY —
PAUL T KELLY —
JULIE A KHANI —
KEVIN N NICHOLSON —
MARC SCHLOSS —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Consumer Product Safety Commission (CPSC); Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); White House Office; Environmental Protection Agency (EPA); Centers For Medicare and Medicaid Services (CMS); Office of Natl Drug Control Policy (NDCP)

Bills named: H.R. 1427 (111th), S. 1383 (111th), S. 726 (111th), S. 1336 (111th), S. 256 (111th), S. 1232 (111th), S. 1406 (111th), H.R. 3663 (111th), H.R. 1548 (111th), H.R. 616 (111th), S. 525 (111th), H.R. 1256 (111th), H.R. 2997 (111th), H.R. 1970 (111th), H.R. 1359 (111th), H.R. 759 (111th), S. 511 (111th), H.R. 2923 (111th), H.R. 1191 (111th), H.R. 3200 (111th), H.R. 1 (111th), H.R. 1298 (111th), S. 956 (111th), H.R. 3108 (111th), H.R. 1259 (111th), H.R. 2552 (111th), H.R. 1450 (111th)

Law Enforcement/Crime/Criminal Justice LAW

H.R. 1173, the Organized Retail Crime Act of 2008, as related to the prosecution of organized theft. H.R. 1166, the E-Fencing Enforcement Act of 2008, as related to the prosecution of organized theft. S. 470, Combating Organized Retail Crime Act of 2009, as related to the prosecution of organized theft.

LobbyistCovered position, as disclosed
STEVEN C ANDERSON —
YONG CHOE —
HEIDI ANN ECKER —
KATHERINE FRY —
CAROL KELLY —
PAUL T KELLY —
JULIE A KHANI —
KEVIN N NICHOLSON —
MARC SCHLOSS —

Contacted: Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Consumer Product Safety Commission (CPSC); SENATE; Office of Natl Drug Control Policy (NDCP); Health & Human Services, Dept of (HHS); Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); White House Office; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1173 (111th), S. 470 (111th), H.R. 1166 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.